Stay updated on Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T00:38:50.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; an older notice about government funding and the previous Revision: v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:01:05.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding lapse notice was added, indicating NIH operations status, and the site revision tag was updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T06:36:38.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Nat Commun publication entry for Fruquintinib plus sintilimab was added and updated from 'Online ahead of print' to the final citation, with related metadata such as a revision tag (v3.4.0) and 'Last Update Submitted that Met QC Criteria'. A new 'Show glossary' control was introduced, and 'No FEAR Act Data' information was added.
    Difference
    0.3%
    Check dated 2026-01-28T04:28:29.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:47:50.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations now include Shanghai Municipality and a new publication citation for Fruquintinib plus sintilimab (Nat Commun 2025). The record revision is updated to v3.3.3, replacing the prior v3.3.2 entry.
    Difference
    0.3%
    Check dated 2025-12-23T21:28:42.000Z thumbnail image

Stay in the know with updates to Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.